Anticancer effect of (E)-2-hydroxy-3′,4,5′-trimethoxystilbene on breast cancer cells by mitochondrial depolarization

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 2, 2011, Pages 349-358

  Chae, Yee Soo ^a   Kim, Jong Gwang ^a   Jung, Hyun Jun ^b   Yang, Jung Dug ^a   Jung, Jin Hyang ^a   Aiyar, Sarah E ^c   Kim, Sanghee ^d   Park, Hoyong ^a,b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Seoul National University   (South Korea)

Author keywords

Apoptosis; Breast cancer; HTMS; Stilbene analog

Indexed keywords

2 HYDROXY 3',4,5' TRIMETHOXYSTILBENE; ANTINEOPLASTIC AGENT; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DEPOLARIZATION; DRUG MECHANISM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MITOCHONDRIAL DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOCHROMES C; ENZYME INHIBITORS; FEMALE; FLUORESCENT DYES; G2 PHASE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; ORGANOMETALLIC COMPOUNDS; PEPTIDE FRAGMENTS; PILOT PROJECTS; POLY(ADP-RIBOSE) POLYMERASES; STILBENES;

EID: 79960909807     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1464-0     Document Type: Article

References (39)

1. GJ Soleas DM Goldberg L Grass M Levesque EP Diamandis 2001 Do wine polyphenols modulate p53 gene expression in human cancer cell lines? Clin Biochem 34 415 420 11522280 10.1016/S0009-9120(01)00246-6 1:CAS:528: DC%2BD3MXnsFSrsLw%3D (Pubitemid 32777852)
2. S Chanvitayapongs B Draczynska-Lusiak AY Sun 1997 Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells Neuroreport 8 1499 1502 9172162 10.1097/00001756-199704140-00035 1:CAS:528:DyaK2sXjvVOhurc%3D (Pubitemid 27242563)
3. B Fauconneau P Waffo-Teguo F Huguet L Barrier A Decendit JM Merillon 1997 Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests Life Sci 61 2103 2110 9395251 10.1016/S0024-3205(97)00883-7 1:CAS:528:DyaK2sXntVKrtLk%3D (Pubitemid 27478837)
4. M Belleri D Ribatti S Nicoli F Cotelli L Forti V Vannini LA Stivala M Presta 2005 Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3, 5, 4′-trimethoxystilbene Mol Pharmacol 67 1451 1459 15703378 10.1124/mol.104.009043 1:CAS:528:DC%2BD2MXktFegsb0%3D (Pubitemid 40594144)
5. M Jang L Cai GO Udeani KV Slowing CF Thomas CW Beecher HH Fong NR Farnsworth AD Kinghorn RG Mehta RC Moon JM Pezzuto 1997 Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 218 220 8985016 10.1126/science.275.5297.218 1:CAS:528:DyaK2sXks1Sjtw%3D%3D (Pubitemid 127696281)
6. KP Bhat JM Pezzuto 2002 Cancer chemopreventive activity of resveratrol Ann N Y Acad Sci 957 210 229 12074974 10.1111/j.1749-6632.2002.tb02918.x 1:CAS:528:DC%2BD38XlvVKnsL8%3D (Pubitemid 34721666)
7. I Blumenstein B Keseru F Wolter J Stein 2005 The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro Clin Cancer Res 11 5651 5656 16061885 10.1158/1078-0432.CCR-04-2674 1:CAS:528:DC%2BD2MXmvFSlsr4%3D (Pubitemid 41060845)
8. Z Dong 2003 Molecular mechanism of the chemopreventive effect of resveratrol Mutat Res 523-524 145 150 12628512 (Pubitemid 36293241)
9. R Lu G Serrero 1999 Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells J Cell Physiol 179 297 304 10228948 10.1002/(SICI)1097-4652(199906)179: 3<297::AID-JCP7>3.0.CO;2-P 1:CAS:528:DyaK1MXjtVaksLs%3D (Pubitemid 29203154)
10. F Scarlatti G Sala G Somenzi P Signorelli N Sacchi R Ghidoni 2003 Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling Faseb J 17 2339 2341 14563682 1:CAS:528:DC%2BD3sXpvVSmsrw%3D (Pubitemid 39561486)
11. S Garvin K Ollinger C Dabrosin 2006 Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo Cancer Lett 231 113 122 16356836 10.1016/j.canlet.2005.01.031 1:CAS:528:DC%2BD2MXhtlaitbnK (Pubitemid 41779459)
12. E Pozo-Guisado JM Merino S Mulero-Navarro MJ Lorenzo-Benayas F Centeno A Alvarez-Barrientos PM Fernandez-Salguero 2005 Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB Int J Cancer 115 74 84 15688415 10.1002/ijc.20856 1:CAS:528:DC%2BD2MXjslejur4%3D (Pubitemid 40559670)
13. M Alkhalaf 2007 Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation Eur J Cancer Prev 16 334 341 17554206 10.1097/01.cej.0000228413.06471.4c 1:CAS:528:DC%2BD2sXpt1ektb4%3D (Pubitemid 47165299)
14. JF Marier P Vachon A Gritsas J Zhang JP Moreau MP Ducharme 2002 Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model J Pharmacol Exp Ther 302 369 373 12065739 10.1124/jpet.102.033340 1:CAS:528:DC%2BD38Xlt1SnsLg%3D (Pubitemid 34680460)
15. M Asensi I Medina A Ortega J Carretero MC Bano E Obrador JM Estrela 2002 Inhibition of cancer growth by resveratrol is related to its low bioavailability Free Radic Biol Med 33 387 398 12126761 10.1016/S0891-5849(02)00911-5 1:CAS:528:DC%2BD38Xlt12kurk%3D (Pubitemid 34786278)
16. T Walle F Hsieh MH DeLegge JE Oatis Jr UK Walle 2004 High absorption but very low bioavailability of oral resveratrol in humans Drug Metab Dispos 32 1377 1382 15333514 10.1124/dmd.104.000885 1:CAS:528:DC%2BD2cXhtFGitrfE (Pubitemid 39564557)
17. M Roberti D Pizzirani D Simoni R Rondanin R Baruchello C Bonora F Buscemi S Grimaudo M Tolomeo 2003 Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents J Med Chem 46 3546 3554 12877593 10.1021/jm030785u 1:CAS:528:DC%2BD3sXltVWlt7k%3D (Pubitemid 36909831)
18. F Peter Guengerich YJ Chun D Kim EM Gillam T Shimada 2003 Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies Mutat Res 523-524 173 182 12628515 (Pubitemid 36293244)
19. Z Ovesna K Horvathova-Kozics 2005 Structure-activity relationship of trans-resveratrol and its analogues Neoplasma 52 450 455 16284688 1:CAS:528:DC%2BD2sXnt1Gnsrk%3D (Pubitemid 41809401)
20. DG Soares AC Andreazza M Salvador 2003 Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems J Agric Food Chem 51 1077 1080 12568575 10.1021/jf020864z 1:CAS:528:DC%2BD3sXitlKntQ%3D%3D
21. S Kim H Ko JE Park S Jung SK Lee YJ Chun 2002 Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors J Med Chem 45 160 164 11754588 10.1021/jm010298j 1:CAS:528:DC%2BD3MXovVKqsrs%3D (Pubitemid 34038551)
22. KA Roupe CM Remsberg JA Yanez NM Davies 2006 Pharmacometrics of stilbenes: seguing towards the clinic Curr Clin Pharmacol 1 81 101 18666380 10.2174/157488406775268246 1:CAS:528:DC%2BD28XitFOnsr8%3D
23. Z Ma O Molavi A Haddadi R Lai RA Gossage A Lavasanifar 2008 Resveratrol analog trans 3, 4, 5, 4′-tetramethoxystilbene(DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol Cancer Chemother Pharmacol 63 27 35 18286288 10.1007/s00280-008-0704-z 1:CAS:528: DC%2BD1cXhtF2kurzP
24. H Park SE Aiyar P Fan J Wang W Yue T Okouneva C Cox MA Jordan L Demers H Cho S Kim RX Song RJ Santen 2007 Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action Cancer Res 67 5717 5726 17575138 10.1158/0008-5472.CAN-07-0056 1:CAS:528:DC%2BD2sXmsFCqsLc%3D (Pubitemid 46985004)
25. S Kim SY Min SK Lee WJ Cho 2003 Comparative molecular field analysis study of stilbene derivatives active against A549 lung carcinoma Chem Pharm Bull (Tokyo) 51 516 521 10.1248/cpb.51.516 1:CAS:528:DC%2BD3sXltVejs7s%3D (Pubitemid 41656802)
26. R Santen MH Jeng JP Wang R Song S Masamura R McPherson S Santner W Yue WS Shim 2001 Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients J Steroid Biochem Mol Biol 79 115 125 11850215 10.1016/S0960-0760(01)00151-0 1:CAS:528: DC%2BD38XhtFyltLk%3D (Pubitemid 34158785)
27. C Dell'Erba B Chiavarina C Fenoglio G Petrillo C Cordazzo E Boncompagni D Spinelli E Ognio C Aiello MA Mariggio M Viale 2005 Inhibition of cell proliferation, cytotoxicity and induction of apoptosis of 1, 4-bis (1-naphthyl)-2, 3-dinitro-1, 3-butadiene in gastrointestinal tumour cell lines and preliminary evaluation of its toxicity in vivo Pharmacol Res 52 271 282 15921920 10.1016/j.phrs.2005.03.011 (Pubitemid 40981929)
28. 2+ release in gastric myocytes from Bufo marinus J Physiol 522 Pt 3 375 390 10713963 10.1111/j.1469-7793.2000.t01-2-00375.x 1:CAS:528:DC%2BD3cXhslaiu74%3D (Pubitemid 30088551)
29. HY Tang A Shih HJ Cao FB Davis PJ Davis HY Lin 2006 Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells Mol Cancer Ther 5 2034 2042 16928824 10.1158/1535-7163.MCT-06-0216 1:CAS:528:DC%2BD28XosVansLs%3D (Pubitemid 44336575)
30. Billam M, Sobolewski MD, Davidson NE (2009) Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast Cancer Res Treat 120:581-592
31. N Zhang X Kong S Yan C Yuan Q Yang 2010 Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis Cancer Sci 101 2375 2383 20718753 10.1111/j.1349-7006.2010.01680.x 1:CAS:528:DC%2BC3cXhsFSgurnP
32. H Okada TW Mak 2004 Pathways of apoptotic and non-apoptotic death in tumour cells Nat Rev Cancer 4 592 603 15286739 10.1038/nrc1412 1:CAS:528:DC%2BD2cXmtVOhsb8%3D (Pubitemid 39025054)
33. T Hirsch I Marzo G Kroemer 1997 Role of the mitochondrial permeability transition pore in apoptosis Biosci Rep 17 67 76 9171922 10.1023/A:1027339418683 1:CAS:528:DyaK2sXjs1Gmu7o%3D (Pubitemid 27267593)
34. JL Scarlett PW Sheard G Hughes EC Ledgerwood HH Ku MP Murphy 2000 Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells FEBS Lett 475 267 272 10869569 10.1016/S0014-5793(00)01681-1 1:CAS:528:DC%2BD3cXktlKqs7Y%3D (Pubitemid 30408466)
35. TA Precht RA Phelps DA Linseman BD Butts SS Le TA Laessig RJ Bouchard KA Heidenreich 2005 The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis Cell Death Differ 12 255 265 15637643 10.1038/sj.cdd.4401552 1:CAS:528:DC%2BD2MXhtlSrtrg%3D (Pubitemid 40360949)
36. DR Green JC Reed 1998 Mitochondria and apoptosis Science 281 1309 1312 9721092 10.1126/science.281.5381.1309 1:CAS:528:DyaK1cXlvVegsLo%3D (Pubitemid 28406816)
37. V Gogvadze S Orrenius B Zhivotovsky 2006 Multiple pathways of cytochrome c release from mitochondria in apoptosis Biochim Biophys Acta 1757 639 647 16678785 10.1016/j.bbabio.2006.03.016 1:CAS:528:DC%2BD28Xmsl2jtLg%3D (Pubitemid 43993852)
38. AI Scovassi GG Poirier 1999 Poly(ADP-ribosylation) and apoptosis Mol Cell Biochem 199 125 137 10544961 10.1023/A:1006962716377 1:CAS:528: DyaK1MXntVOhs78%3D (Pubitemid 29476151)
39. MH Jeng MA Shupnik TP Bender EH Westin D Bandyopadhyay R Kumar S Masamura RJ Santen 1998 Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells Endocrinology 139 4164 4174 9751496 10.1210/en.139.10.4164 1:CAS:528:DyaK1cXmsVGnu78%3D (Pubitemid 28513702)